These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11313984)

  • 21. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genes.
    Wada T; Berggren P; Steineck G; Adolfsson J; Wijkström H; Norming U; Hansson J; Hemminki K; Larsson P
    Scand J Urol Nephrol; 2003; 37(2):106-11. PubMed ID: 12745717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
    Habuchi T; Devlin J; Elder PA; Knowles MA
    Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.
    Williams SV; Sibley KD; Davies AM; Nishiyama H; Hornigold N; Coulter J; Kennedy WJ; Skilleter A; Habuchi T; Knowles MA
    Genes Chromosomes Cancer; 2002 May; 34(1):86-96. PubMed ID: 11921286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer.
    Dudziec E; Miah S; Choudhry HM; Owen HC; Blizard S; Glover M; Hamdy FC; Catto JW
    Clin Cancer Res; 2011 Mar; 17(6):1287-96. PubMed ID: 21138856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer.
    Christoph F; Hinz S; Kempkensteffen C; Weikert S; Krause H; Schostak M; Schrader M; Miller K
    J Cancer Res Clin Oncol; 2007 Jun; 133(6):343-9. PubMed ID: 17160380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Promoter methylation and microsatellite mutation reveals the clonal relationship of multiple urothelial carcinomas with mutator phenotype].
    Stöhr R; Catto JW; Azzouzi A; Rehmann I; Feeley K; Meuth M; Hamdy F; Burger M; Hartmann A
    Verh Dtsch Ges Pathol; 2005; 89():225-33. PubMed ID: 18035696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
    Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MGMT hypermethylation and BCL-2 overexpression associated with superficial bladder cancer and recurrence.
    Jahed M; Ebadi N; Mivehchi M; Majidizadeh T; Shahshanipour M; Asgari M; Ghadakzadeh S; Hosseini SA
    Cancer Biomark; 2016 Mar; 16(4):627-32. PubMed ID: 27002765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic inactivation of KLF4 is associated with urothelial cancer progression and early recurrence.
    Li H; Wang J; Xiao W; Xia D; Lang B; Wang T; Guo X; Hu Z; Ye Z; Xu H
    J Urol; 2014 Feb; 191(2):493-501. PubMed ID: 24018236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
    Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW
    J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder.
    Abbosh PH; Wang M; Eble JN; Lopez-Beltran A; Maclennan GT; Montironi R; Zheng S; Pan CX; Zhou H; Cheng L
    Mod Pathol; 2008 Mar; 21(3):355-62. PubMed ID: 18192966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.